SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

ImmunityBio, Inc. is a clinical stage immunotherapy company. It develops next generation therapies that drive immunogenic mechanisms for defeating cancers and infectious diseases. The company's immunotherapy platform activates both the innate and adaptive immune systems to create long term immunological memory. ImmunityBio was founded by Patrick Soon-Shiong in 2014 and is headquartered in San Diego, CA.

ImmunityBio Inc

ImmunityBio is currently trending as retail investors speculate on potential inclusion in the Russell 1000 index, fueling intense debate regarding the stock's future liquidity and its ongoing battle between bullish long-term sentiment and heavy short interest. While the community remains divided over the outcome of index rebalancing, investors are primarily focused on upcoming regulatory milestones and the long-term commercialization potential of the company's immunotherapy platform.

ON Semiconductor Corp. engages in the provision of intelligent power and sensing solutions with a primary focus on automotive and industrial markets. It operates through the following segments: Power Solutions Group (PSG), Analog and Mixed-Signal Group (AMG), and Intelligent Sensing Group (ISG). The PSG segment offers discrete, module, and integrated semiconductor products that perform multiple application functions, including power switching, signal conditioning, and circuit protection. The AMG segment designs and develops analog, mixed-signal, power management integrated circuits, sensor interface devices, power conversion, signal chain, and voltage regulation devices. The ISG focuses on the design and development of complementary metal oxide semiconductor image sensors, image signal processors, single photon detectors, including silicon photomultipliers, single photon avalanche diode arrays, and short-wavelength infrared products, as well as actuator drivers for autofocus and image stabilization. The company was founded on July 4, 1999 and is headquartered in Scottsdale, AZ.

ON Semiconductor Corp.

ON Semiconductor is trending due to a 21% share price drop following the announcement of a $7 billion all-stock acquisition of Synaptics, which has triggered widespread concerns among investors regarding equity dilution. The community is actively debating the strategic long-term value of the deal versus near-term risks, with many traders speculating on an arbitrage-driven recovery or further downside volatility.

Sable Offshore Corp. engages in offshore oil and gas field operations. It focuses on developing the prolific Santa Ynez Unit in federal waters offshore California. The company was founded by James C. Flores on October 16, 2020 and is headquartered in Houston, TX.

Sable Offshore Corp.

Sable Offshore is capturing significant investor attention as operations ramp up and the company secures key off-take agreements, fueling debates over the stock's potential for a major short squeeze. While community members are divided between concerns over ongoing legal challenges with California regulators and optimism regarding strong federal support and high-margin production, the stock remains a focal point for those betting on the company's ability to navigate these institutional and political hurdles.

Candel Therapeutics, Inc. is a clinical stage biotechnology company, which engages in the development and commercialization of viral immunotherapies. Its pipeline includes CAN-2409 and CAN-3110. The company was founded by Estuardo Aguilar-Cordova in 2002 and is headquartered in Needham, MA.

Candel Therapeutics Inc

Candel Therapeutics is experiencing heightened investor attention driven by anticipation surrounding its NSCLC Phase 3 clinical trial initiation and strategic management moves, including the appointment of a new Chief Commercial Officer. While the community is actively debating the stock's potential for a major buyout and its valuation relative to upcoming regulatory milestones, market participants are also monitoring unusual volume patterns and institutional activity ahead of these key developments.

AbCellera Biologics, Inc. engages in the development of therapeutic antibodies. It offers antibody discovery platform that searches, decodes and analyzes natural immune systems to find antibodies that can be developed to prevent and treat disease. The company was founded by Carl Lars G. Hensen, Kathleen Lisaingo, Kevin Heyries, Véronique Lecault and Daniel Da Costa on November 8, 2012 and is headquartered in Vancouver, Canada.

AbCellera Biologics Inc

AbCellera Biologics is trending following a recent strategic collaboration with Jazz Pharmaceuticals and growing investor focus on the company's AI-driven drug discovery platform. The community is actively discussing heavy trading volume, a recent breakout in price action, and anticipation regarding upcoming clinical data readouts.

REalloys, Inc. is engaged in the rebuilding of domestic supply chain resilience for rare earth elements and magnets. It is involved in recycling, mining, oxide production, metallization, alloying, and magnet manufacturing. The company was founded on October 4, 2011 and is headquartered in Boca Raton, FL.

REalloys Inc.

REalloys Inc. is trending as investors focus on its strategic pivot to build a domestic, China-free rare earth supply chain and its upcoming inclusion in the Russell 3000 index. Community discussion is dominated by the companys landmark offtake agreements and potential for government-backed financing to accelerate their midstream processing operations.

Icahn Enterprises LP is a holding company. It operates through the following segments: Investment, Automotive, Energy, Food Packaging, Real Estate, Home Fashion, Pharma, and Holding Company. The Investment segment consists of various private investment funds. The Automotive segment holds ownership in Icahn Automotive Group, LLC. The Energy segment refers to petroleum refining and marketing businesses. The Food Packaging segment involves the production and sale of cellulosic, fibrous, and plastic casings for the processed meat and poultry industry. The Real Estate segment offers rental real estate, property development, and resort activities. The Home Fashion segment deals with manufacturing, sourcing, marketing, distributing, and selling home fashion consumer products. The Pharma segments operate through Vivus, Inc., a specialized pharmaceutical company. The Holding Company segment manages acquisition and investment in operating businesses. The company was founded on February 17, 1987 and is headquartered in Sunny Isles Beach, FL.

Icahn Enterprises L P - Unit

Icahn Enterprises, L.P.

Icahn Enterprises is seeing renewed investor interest driven by a strategic pivot toward energy and potential upside from subsidiary holdings, despite ongoing concerns regarding dilution and the sustainability of its quarterly distributions. The community is closely watching upcoming earnings and operational developments, with many retail holders maintaining long-term positions in anticipation of a potential reversal in share price.

Onyx is an infrastructure for a multi-asset, scalable, and cryptographically secure ledger. Onyx functions as a blockchain-based technology that enhances financial ecosystems by enabling a more efficient and interconnected economy, with a mission to develop cryptographic ledgers that optimize security, scalability, and usability. XCN is native to the Onyx XCN Ledger Blockchain as well as the Onyx Goliath Blockchain. XCN is also used as an ERC-20 token for Staking and Governance.

Onyxcoin

Onyxcoin is seeing increased community activity fueled by anticipation for the upcoming Goliath mainnet launch and discussions around its potential role in institutional financial infrastructure. While some investors are bullish on the network upgrade and long-term utility, others remain skeptical, warning of historical price volatility and questioning the transparency of the project's development team.

Bristol Myers Squibb Co. engages in the discovery, development, licensing, manufacture, marketing, distribution, and sale of biopharmaceutical products. It offers small molecules, products produced from biological processes called biologics, and chimeric antigen receptor (CAR-T) cell therapies. The company was founded in August 1933 and is headquartered in Princeton, NJ.

Bristol-Myers Squibb Co.

Bristol-Myers Squibb is trending as investors digest positive pipeline updates, including the decision to continue the Phase 3 ADEPT-2 trial for Cobenfy and a new FDA approval for Breyanzi in marginal zone lymphoma. The community is actively discussing the company's valuation, dividend stability, and the potential for long-term growth as they navigate ongoing challenges related to the upcoming patent cliff.

Lucid Group, Inc. manufactures electric vehicles. It designs, develops, and builds energy storage systems for electric vehicles and supplies automakers with the battery pack system needed to power hybrid, plug-in, and electric vehicles. The company was founded in December 2007 and is headquartered in Newark, CA.

Lucid Group Inc

Lucid Group is experiencing heightened volatility following the official announcement of a mid-2027 robotaxi service in Houston in partnership with Uber and Nuro. While the community remains deeply divided, with many expressing concern over management turnover and cash flow, others are focused on potential short-squeeze activity as traders closely monitor high short-interest levels and borrow rates.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

$CRAI
Current Stock Price: $166.88
Contracts to trade: $155.0 CRAI Feb 20 2026 Call
Entry: $9.10
Exit: $13.90
ROI: 53%
Hold ~29 days

Shared as daily free alerts and for educational purposes only. https://dailypickai.com/freealerts

AI Powered Insights Get daily AI-generated picks that are primed to give you an edge. Join thousands of users who are getting smarter with our insights. Join thousands of users getting insightful AI-powered content delivered daily. 100% Free * No Credit Card Required * Disclaimer: The information provided is for educational purposes only and should not be considered professional advice.

Dailypickai

DailyPickAI

StockTwits Web

CRA International Inc.


Current Stock Price: $166.88
Contracts to trade: $155.0 CRAI Feb 20 2026 Call
Entry: $9.10
Exit: $13.90
ROI: 53%
Hold ~29 days

Shared as daily free alerts and for educational purposes only. 